Correlation Between Health Catalyst and Streamline Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Health Catalyst and Streamline Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Health Catalyst and Streamline Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Health Catalyst and Streamline Health Solutions, you can compare the effects of market volatilities on Health Catalyst and Streamline Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Health Catalyst with a short position of Streamline Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Health Catalyst and Streamline Health.

Diversification Opportunities for Health Catalyst and Streamline Health

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Health and Streamline is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Health Catalyst and Streamline Health Solutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Streamline Health and Health Catalyst is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Health Catalyst are associated (or correlated) with Streamline Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Streamline Health has no effect on the direction of Health Catalyst i.e., Health Catalyst and Streamline Health go up and down completely randomly.

Pair Corralation between Health Catalyst and Streamline Health

Given the investment horizon of 90 days Health Catalyst is expected to under-perform the Streamline Health. But the stock apears to be less risky and, when comparing its historical volatility, Health Catalyst is 2.01 times less risky than Streamline Health. The stock trades about -0.13 of its potential returns per unit of risk. The Streamline Health Solutions is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  220.00  in Streamline Health Solutions on November 20, 2024 and sell it today you would earn a total of  147.00  from holding Streamline Health Solutions or generate 66.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Health Catalyst  vs.  Streamline Health Solutions

 Performance 
       Timeline  
Health Catalyst 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Health Catalyst has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Streamline Health 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Streamline Health Solutions are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Streamline Health displayed solid returns over the last few months and may actually be approaching a breakup point.

Health Catalyst and Streamline Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Health Catalyst and Streamline Health

The main advantage of trading using opposite Health Catalyst and Streamline Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Health Catalyst position performs unexpectedly, Streamline Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Streamline Health will offset losses from the drop in Streamline Health's long position.
The idea behind Health Catalyst and Streamline Health Solutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments